The Precision Medicine Institute's E-briefings deliver news and intelligence articles about the latest precision medicine topics to keep health system, hospital, and medical executives and administrators on the cutting edge of this rapidly changing field

Explore E-Briefings

E-briefings are published weekly and are listed below, with the most recent at the top. You may filter by topic and access dozens of additional articles using the page navigation below. Check back often to access new articles online or subscribe to have each new article delivered straight to your inbox weekly!

University of Helsinki Researchers Find Functional Precision Medicine Offers Superior Approach to Leukemia Treatments

The approach combined deep molecular profiling with comprehensive drug sensitivity testing for patients where standard therapy alternatives had been exhausted.

Memorial Sloan Kettering Cancer Center Gains FDA Partial Recognition of its OncoKB Oncology Knowledge Database

A recently FDA-recognized somatic cancer database organizes tumor genomic profiling and cancer drugs into levels of clinical evidence that can be used by hospital and oncology leaders.

Mount Sinai Researchers Find Cancer Treatment Implications Based on Age-Dependent Cancer Genetics

Comprehensive assessment of young adult tumors across multiple cancer types reveals age-related cancer genetics that are important to treatment decisions.

Newly Discovered Imaging Biomarkers Enable Hospitals to Predict Patients’ Response to Antidepressant Therapy

UT Southwestern Medical Center research has discovered imaging biomarkers that can predict what response patients will have to antidepressant medications.

Precision Medicine Research for Pulmonary Fibrosis May Bring New Treatments Closer

Personalized treatments for idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (IDLs) step closer to reality as new study techniques and improved funding advance research.

Precision Medicine Study Shows Failed Cancer Medicine May Actually Be Effective for Aggressive Breast Cancers

Renewed interest in abandoned drugs for specific subsegments of certain healthcare populations could lead to new personalized treatments for cancer and other chronic diseases.

Genetic Sequencing Alone May Not Be Enough to Optimize Precision Medicine Treatment, Harvard and MIT Researchers Find

Researchers have found that cancer cells have different states in which different sets of genes are expressed, influencing what drugs will be effective for those cells given that specific point in time.

Precision Medicine Blood Test Predicts Depression During and After Pregnancy, Allowing Early Clinical Intervention

Van Andel Institute and Pine Rest researchers have developed biomarkers that appear to accurately predict risk of severe depression during or after pregnancy.

Walmart Plans to Use Precision Medicine AI Technology to Expand the Company’s Influence in Healthcare

Walmart’s large size and vast resources should cause strategic-minded healthcare leaders to pay attention to moves the retail company is making.

Swiss Researchers Show That Hospitals Can Use Precision Medicine to Improve Effectiveness of Peritoneal Dialysis

Researchers from the University of Zurich found that a genetic variation present in about 30% of the population can affect how effective peritoneal dialysis is for these patients. Hospital leaders should be aware of this new precision medicine-based discovery.